Product Information
MESALAMINE ER 500 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $3.4704 per EA under NDC 63304008913. Its NADAC has been published 200 times since Aug 17, 2022.
Strength
500 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304008913
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/18/2025
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214585On Market Since
5/13/2022
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 500 MG CAPSULE has been published 200 times since Aug 17, 2022, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4704 per EA |
|---|---|
| All-time high | $5.2137 (May 15, 2024) |
| All-time low | $3.4704 (Jun 18, 2025) |
| 52-week high | $3.4704 |
| 52-week low | $3.4704 |
| Median price | $4.2223 |
| Average price | $4.1890 |
| Largest weekly change | -12.2% (Mar 22, 2023) |
| Weeks tracked | 200 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Mesalamine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MESALAMINE ER 500 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 500 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $3.4704 per EA (NDC 63304008913), effective Jun 10, 2026.
How has the price of MESALAMINE ER 500 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 500 MG CAPSULE has declined 21.1%. It has been tracked across 200 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 500 MG CAPSULE?
Since Aug 17, 2022, the NADAC for MESALAMINE ER 500 MG CAPSULE has ranged from a low of $3.4704 (Jun 18, 2025) to a high of $5.2137 (May 15, 2024), with a median of $4.2223 per EA.
Are there cheaper alternatives to MESALAMINE ER 500 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MESALAMINE ER 500 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures MESALAMINE ER 500 MG CAPSULE?
MESALAMINE ER 500 MG CAPSULE (NDC 63304008913) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification